Effects of Abciximab on the Architecture of Platelet-Rich Clots in Patients With Acute Myocardial Infarction Undergoing Primary Coronary Intervention
- 15 May 2001
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Circulation
- Vol. 103 (19) , 2328-2331
- https://doi.org/10.1161/01.cir.103.19.2328
Abstract
Background—Abciximab plus aspirin improves the TIMI 3 flow rate of the infarct-related artery in patients treated with either percutaneous coronary intervention or thrombolysis. The present study i...Keywords
This publication has 7 references indexed in Scilit:
- High dose heparin as pretreatment for primary angioplasty in acute myocardial infarction: the Heparin in Early Patency (HEAP) randomized trialJournal of the American College of Cardiology, 2000
- Abciximab in the treatment of acute myocardial infarction eligible for primary percutaneous transluminal coronary angioplasty: Results of the glycoprotein receptor antagonist patency evaluation (GRAPE) pilot studyJournal of the American College of Cardiology, 1999
- A Clinical Trial Comparing Primary Coronary Angioplasty with Tissue Plasminogen Activator for Acute Myocardial InfarctionNew England Journal of Medicine, 1997
- Heparin Ablates Force Development during Platelet Mediated Clot RetractionThrombosis and Haemostasis, 1996
- A torsion pendulum for measurement of the viscoelasticity of biopolymers and its application to actin networksJournal of Biochemical and Biophysical Methods, 1991
- Native fibrin gel networks observed by 3D microscopy, permeation and turbidityBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1989